Latest Content
Solid proof now exists that pharmacological intervention can help shift excess body weight. Yet, many questions remain, including:
What’s the potential market size?
How much is the pipeline worth?
Which mechanisms show the most promise?
Where are investors...
Read More
Navigating the complex landscape of rare diseases requires a specialized approach. With over 7,000 types of rare diseases affecting more than 300 million people globally, and only a fraction having approved treatments, forecasting their market potential...
Read More
Going into 2024, hopes were moderately high for dealmaking and the wider financial landscape in pharma. M&A and IPOs were picking up, offering investors the exit opportunities they need. But the second quarter of the year took several steps back,...
Read More
